JPH03236847A - Drug-contained receptacle having plural chambers - Google Patents

Drug-contained receptacle having plural chambers

Info

Publication number
JPH03236847A
JPH03236847A JP2033515A JP3351590A JPH03236847A JP H03236847 A JPH03236847 A JP H03236847A JP 2033515 A JP2033515 A JP 2033515A JP 3351590 A JP3351590 A JP 3351590A JP H03236847 A JPH03236847 A JP H03236847A
Authority
JP
Japan
Prior art keywords
chamber
communication
chambers
communicating
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2033515A
Other languages
Japanese (ja)
Inventor
Keinosuke Isono
啓之介 磯野
Tatsuo Suzuki
鈴木 龍夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Material Engineering Technology Laboratory Inc
Original Assignee
Material Engineering Technology Laboratory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Material Engineering Technology Laboratory Inc filed Critical Material Engineering Technology Laboratory Inc
Priority to JP2033515A priority Critical patent/JPH03236847A/en
Priority to DE69111480T priority patent/DE69111480T2/en
Priority to EP19910101846 priority patent/EP0442406B1/en
Priority to US07/654,037 priority patent/US5114004A/en
Publication of JPH03236847A publication Critical patent/JPH03236847A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

PURPOSE:To surely keep plural drugs in isolation until they are used and to mix the same easily in air-tight condition at the time of use by screening a communicating chamber formed by communicating means, by means of a member for forming one chamber, and breaking the member for forming the chamber so as to mix drugs sealed in the chambers through the communicating chamber. CONSTITUTION:A receptacle 1 comprises an entrance portion 2, a receptacle portion 3 and a suspension opening portion 4, wherein the receptacle portion 3 is separated into the first chamber 5 and the second chamber 6 by an isolation means 7. A communi cating means 8 is liquid-tightly welded on the outer surface of the receptacle portion 3 in such a manner as to stride over the isolation means 7, and the first chamber 5 and the second chamber 6 are connected to each other by the communicating means 8. Different drugs are poured into the first chamber 5 and the second chamber 6, and the entrance portion 2 is sealed up by a cap 10. The suspension opening portion 4 has a suspension opening 9 to be caught by a suspension base. The communicating means 8 comprises a communication element 21, breaking members 22, 23 and a bearer 24, wherein the communication element 21 is pressed, a plastic sheet 27 of a member forming the first chamber 5 and the second chamber 6 are pierced by the breaking members 22, 23 to mix the drugs sealed in the chambers 5, 6 in the receptacle portion 3.

Description

【発明の詳細な説明】 [産業上の利用分野コ 本発明は、複数の室を有する薬剤入り容器に間する。特
に、クローズド医療システムに用いられる高カロリー輸
液剤やニレメンタルダイエツト(以下EDと略す〉の成
分で互いに反応しゃすい成分を複数種入れることのでき
る変形可能な薬剤入り容器に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a container containing a drug having a plurality of chambers. In particular, the present invention relates to a deformable drug-containing container that can contain a plurality of components that react with each other, such as high-calorie infusion solutions and elemental diets (hereinafter abbreviated as ED) used in closed medical systems.

[従来の技術] 近年生体に必要な栄養素すべてを経静脈より摂取する高
カロリー輸液法がさかんに行われるようになってきた。
[Prior Art] In recent years, high-calorie infusion methods for ingesting all the nutrients necessary for living organisms through veins have become popular.

高カロリー輸液法が適用されるのは、消化管縫合不全、
消化管通過障害等の経口摂取が不十分または不可能な場
合、炎症性腸疾患、重症下痢等の経口摂取が好ましくな
い場合、広範熱傷、多発重症外傷等の経腸補給を上回る
高カロリー補給が望まれる場合、肝不全・腎臓不全、糖
尿病等の疾患による代謝の特異性を応用する場合などで
ある。
High calorie infusion method is applied for cases of gastrointestinal sutural incompetence,
In cases where oral intake is insufficient or impossible due to gastrointestinal transit disorders, cases where oral intake is not desirable due to inflammatory bowel disease, severe diarrhea, etc., high-calorie supplementation that exceeds enteral supplementation is required in cases such as extensive burns or multiple severe injuries. If desired, metabolic specificities due to diseases such as liver failure, kidney failure, or diabetes may be applied.

高カロリー輸液法に用いられる高カロリー輸液剤は生体
に必要な栄養素をすべて適量含むことが基本である。す
なわち、糖質、アミノ酸、脂質、主要電解質、微量金属
及びビタミンを含む多成分輸液剤になる。しかし、これ
らのすべてを含む複合液を製品化することは配合性、安
定性の面で現在は不可能である。そこで、現在三つの方
法が用いられている。
The high-calorie infusion preparation used in the high-calorie infusion method basically contains all the nutrients necessary for the living body in appropriate amounts. That is, it is a multicomponent infusion containing carbohydrates, amino acids, lipids, major electrolytes, trace metals, and vitamins. However, it is currently impossible to commercialize a composite liquid containing all of these in terms of blendability and stability. Therefore, three methods are currently used.

■市販の高カロリー輸液用基本液を用いる。高濃度ブド
ウ糖液に主要電解質が配合された液で、使用時アミノ酸
を混合し、ビタミン及び不足な電解質を添加する。
■Use a commercially available high-calorie infusion base solution. This is a high concentration glucose solution mixed with major electrolytes, and when used, amino acids are mixed, and vitamins and insufficient electrolytes are added.

■市販の高張ブドウ糖液とアミノ酸液を混合又は両方を
連結して投与する。
■Administer commercially available hypertonic glucose solution and amino acid solution by mixing them or by combining both.

■高カロリー輸液基本液又はブドウ糖液を独自に薬局製
剤室で作成する。
■High-calorie infusion basic solution or glucose solution is prepared independently in the pharmacy formulation room.

いずれにしても、高カロリー輸液用基本液又は高張ブド
ウ糖液にアミノ酸液を使用時に混合して患者に投与する
わけである。
In any case, the amino acid solution is mixed with the basic solution for high-calorie infusion or the hypertonic glucose solution at the time of use and administered to the patient.

[発明が解決しようとする問題点] 従来ブドウ糖アミノ酸を配合して一液製剤とし容器に封
入すると、高圧蒸気滅菌時及び保存時にブドウ糖とアミ
ノ酸との間で反応が起こり輸液剤が着色していた。この
ため、上述したように現在のところブドウ糖とアミノ酸
のように互いに反応しやすい成分を含む薬剤を混合して
一液製剤とすることができず、これらの薬液を使用時に
混合して患者に投与している。また、EDのような溶液
状態で保存しておくと、安定性が失われ長期保存できな
いものは、粉末状の薬剤と溶液状のものに分離して保存
しておき、使用直前に混合して患者に投与している。こ
のように、使用時に混合するという操作は、調剤ミスを
起こす可能性があり、また混合時の汚染等の問題がある
[Problems to be solved by the invention] Conventionally, when glucose and amino acids were blended into a one-component formulation and sealed in a container, a reaction occurred between the glucose and the amino acid during high-pressure steam sterilization and storage, resulting in coloring of the infusion solution. . For this reason, as mentioned above, it is currently not possible to mix drugs that contain components that easily react with each other, such as glucose and amino acids, into a one-component preparation, and these drug solutions must be mixed at the time of use and administered to patients. are doing. In addition, for drugs such as ED that cannot be stored for long periods of time due to loss of stability if stored in a solution state, separate the drug into a powdered drug and a solution and mix them together immediately before use. administered to patients. As described above, the operation of mixing at the time of use may lead to dispensing errors, and there are also problems such as contamination during mixing.

さらに、近年、ホームへルスケアが注目されてきており
、将来、家庭内で輸液等を容易に実施できるように、複
数の薬剤を間違い無く確実に混合できるシステムが望ま
れている。
Furthermore, in recent years, home health care has been attracting attention, and in the future there is a desire for a system that can reliably mix multiple drugs without making mistakes so that infusions can be easily performed at home.

本発明は、互いに反応しやすい成分を含む薬剤を安定し
た状態で滅菌及び長期保存できる複数の室を有する薬剤
入り容器を提供することにある。
An object of the present invention is to provide a drug-containing container having a plurality of chambers that can stably sterilize and store drugs containing components that are likely to react with each other for a long period of time.

E問題点を解決するための手段] 前述したように、互いに反応する成分を含む薬剤を一液
製剤にしておくと、滅菌時及び長期保存時に薬液が変色
或は変質してしまうので、使用時に混合する必要がある
。この混合時に調剤ミスや汚染等の問題が発生していた
。かかる問題を解決するためには、複数の室を有する容
器を形成し、それぞれの室に互いに反応しやすい成分を
含む薬剤を隔離して所定量を封入しておき、使用時にこ
れらの複数の室を互いに連通させて容器内で前記薬剤を
混合することにより上記問題点を解決することができる
Measures to Solve Problem E] As mentioned above, if drugs containing components that react with each other are made into one-part preparations, the drug solution will change color or deteriorate during sterilization or long-term storage, so be careful when using it. Need to mix. Problems such as dispensing errors and contamination have occurred during this mixing. In order to solve this problem, a container with multiple chambers is formed, and each chamber is filled with a predetermined amount of drugs containing components that are likely to react with each other. The above-mentioned problems can be solved by communicating the drugs with each other and mixing the drugs in the container.

本発明は、複数の薬剤を使用時まで確実に隔離でき、使
用時には容易に複数の薬剤を密閉状態で混合することが
できる容器を提供するために、発明者らは、種々の検討
をおこなった結果、複数の室とそれぞれの室を連結する
連通手段からなる容器であって、前記連通手段で構成さ
れる連通室は少なくとも一方の室を構成する部材によっ
て遮蔽されており、前記室を構成する部材を破壊するこ
とにより前記連通手段で構成される連通室を介してそれ
ぞれの室に封入されている薬剤を混合することができる
複数の室を有する薬剤入り容器を提供することができる
ことが分かった。
The present invention has been made by the inventors in order to provide a container that can reliably isolate multiple drugs until they are used, and that can easily mix multiple drugs in a sealed state during use. As a result, the container is made up of a plurality of chambers and communication means for connecting the respective chambers, and the communication chamber constituted by the communication means is shielded by a member constituting at least one of the chambers, It has been found that by destroying the member, it is possible to provide a drug-containing container having a plurality of chambers in which the drugs sealed in the respective chambers can be mixed through the communication chambers constituted by the communication means. .

[作用] 次に、本発明を図面に基づいて具体的に説明する。[Effect] Next, the present invention will be specifically explained based on the drawings.

本発明によって製造される複数の室を有する薬剤入り容
器1を第1図に示す、容器1は、口元部2、容器部3、
懸垂口部4から構成されている。
FIG. 1 shows a drug-containing container 1 having a plurality of chambers manufactured according to the present invention.
It is composed of a hanging opening part 4.

容器部3は隔離手段7により第−室5と第二室6に分離
されている。隔離手段7を跨ぐように容器部3の外面に
連通手段8が液密に溶着され、第−室5と第二室6を連
通手段8が連結している。第−室5と第二室6にはそれ
ぞれ異なる薬剤が注入されており、口元部2は栓10に
より密封されている。また、懸垂口部4は、懸垂台に引
っ掛けるための懸垂口9を有している。
The container section 3 is separated into a first chamber 5 and a second chamber 6 by an isolation means 7. A communication means 8 is liquid-tightly welded to the outer surface of the container portion 3 so as to straddle the isolation means 7, and connects the first chamber 5 and the second chamber 6. Different drugs are injected into the first chamber 5 and the second chamber 6, and the mouth part 2 is sealed with a stopper 10. Further, the suspension opening portion 4 has a suspension opening 9 for hanging on a suspension table.

連通手段8は種々の形態が考えられる。連通手段の第一
実施例の具体的な形態を第2図に示す。
The communication means 8 can take various forms. A specific form of the first embodiment of the communication means is shown in FIG.

連通手段は、連通体21と破壊部材22.23と受台2
4で構成されている。連通体21は、伸縮可能な蛇腹状
の形状を有している。連通体21は容器部3の一方の外
面に液密に溶着され、連通室25を形成している。破壊
部材22.23は、連通体21の内部に固定されている
。受台24は、連通体21が溶着されている反対側の容
器部の他方の外面に液密に溶着され、連通室26を形成
している。この連通室26は、必ずしも必要とはしない
。すなわち、第−室5と第二室6の連通路として、連通
室25が存在するからである。また、本容器の保存中あ
るいは輸送中に、破壊部材22.23がプラスチックシ
ート27を貫通しないように、連通体21の蛇腹部分が
伸縮しないように第12図に示すようなストッパー53
を設けてもよい。
The communication means includes the communication body 21, the destruction member 22, 23, and the pedestal 2.
It consists of 4. The communication body 21 has a bellows-like shape that can be expanded and contracted. The communication body 21 is liquid-tightly welded to one outer surface of the container portion 3 to form a communication chamber 25. Destructive members 22 , 23 are fixed inside the communication body 21 . The pedestal 24 is liquid-tightly welded to the other outer surface of the container portion on the opposite side to which the communication body 21 is welded, and forms a communication chamber 26 . This communication chamber 26 is not necessarily required. That is, this is because the communication chamber 25 exists as a communication path between the first chamber 5 and the second chamber 6. In addition, a stopper 53 as shown in FIG. 12 is provided to prevent the bellows portion of the communication body 21 from expanding and contracting so that the destructive members 22 and 23 do not penetrate the plastic sheet 27 during storage or transportation of the container.
may be provided.

連通体21を外部から押さえ込み、破壊部材22.23
で第−室5及び第二室6を形成している部材であるプラ
スチックシート27を貫通させる。そのときの状態を第
3図に示す。このとき、2枚のプラスチックシート27
を貫通させているが、1枚のプラスチックシートのみを
貫通させるだけでもよい。
The communication body 21 is pressed down from the outside, and the destruction members 22 and 23 are
The plastic sheet 27, which is the member forming the first chamber 5 and the second chamber 6, is penetrated. The state at that time is shown in FIG. At this time, two plastic sheets 27
, but it is also possible to penetrate only one plastic sheet.

この場合は、受台24は必要としないので、受台のない
連通手段の実施例も考えられる。さらに、連通室25は
密閉状態であり、内部の空気が圧縮され、破壊部材22
.23をプラスチックシート27に貫通させるのに大き
な力が必要な場合は、連通体21の一部に疎水性のフィ
ルターを取り付けておくのが好ましい。疎水性のフィル
ターは、水溶液は通過させないが空気は通すので、連通
室25の内部の圧力上昇させずに容易に破壊部材22.
23をプラスチックシート27に貫通させることができ
る。
In this case, since the pedestal 24 is not required, an embodiment of the communication means without a pedestal is also conceivable. Furthermore, the communication chamber 25 is in a sealed state, the air inside is compressed, and the destruction member 22
.. If a large force is required to penetrate the plastic sheet 27 through the passage 23, it is preferable to attach a hydrophobic filter to a part of the communication body 21. Since the hydrophobic filter does not allow aqueous solution to pass through it, but allows air to pass through it, it is easy to remove the destruction member 22. without increasing the pressure inside the communication chamber 25.
23 can be passed through the plastic sheet 27.

次に、連通体21を元に戻す、そのときの状態を第4図
に示す。第−室5及び第二室6にはそれぞれ貫通口28
.29ができ、第−室5と第二室6は連通室25.26
で連通され、第−室5と第二室6に封入されていた薬剤
が容器部3の中で混合される。
Next, the communicating body 21 is returned to its original state, and the state at that time is shown in FIG. Through holes 28 are provided in the first chamber 5 and the second chamber 6, respectively.
.. 29 is created, and the first chamber 5 and second chamber 6 are communication chambers 25.26
The medicines sealed in the first chamber 5 and the second chamber 6 are mixed in the container part 3.

第2図に示した第一実施例の連通手段8の連通体21の
構造は、伸縮可能な蛇腹状の形状のものについて示した
が、伸縮可能な形状であればどのような形状でも良く、
また連通体を形成する素材に伸縮可能なゴム状の材質を
用いても良く、蛇腹状の形状に限定されるものではない
Although the structure of the communication body 21 of the communication means 8 of the first embodiment shown in FIG. 2 is shown in the form of an expandable bellows, it may have any shape as long as it is expandable.
Further, the material forming the communication body may be made of a stretchable rubber-like material, and is not limited to a bellows-like shape.

また、連通手段8の別の形態を第5図に示す。Further, another form of the communication means 8 is shown in FIG.

連通手段は、連通体31と破壊部材32とOリング33
と受台34で構成されている。連通体31と破壊部材3
2はOリング33を用いて液密に摺動可能なように組み
立てられている。連通体31は容器部3の一方の外面に
液密に溶着され、連通室35を形成している。受台34
は、連通体31が溶着されている反対側の容器部の他方
の外面に液密に溶着され、連通室36を形成している。
The communication means includes a communication body 31, a breaking member 32, and an O-ring 33.
and a pedestal 34. Communication body 31 and destruction member 3
2 is assembled using an O-ring 33 so that it can slide in a liquid-tight manner. The communication body 31 is liquid-tightly welded to one outer surface of the container portion 3 to form a communication chamber 35. pedestal 34
is liquid-tightly welded to the other outer surface of the container portion on the opposite side to which the communicating body 31 is welded, forming a communicating chamber 36.

破壊部材32を外部から押さえ込み、破壊部材32で第
−室5及び第二室6を形成しているプラスチックシート
37を貫通させる。そのときの状態を第6図に示す。
The destructive member 32 is pressed down from the outside, and the plastic sheet 37 forming the first chamber 5 and the second chamber 6 is penetrated by the destructive member 32. The state at that time is shown in FIG.

次に、破壊部材32を元に戻す。そのときの状態を第7
図に示す。第−室5および第二室6にはそれぞれ貫通口
38.39ができ、第−室5と第二室6は連通室35.
36で連通され、第−室5と第二室6に封入されていた
薬剤が容器部3の中で混合される。
Next, the destruction member 32 is returned to its original position. The state at that time is the seventh
As shown in the figure. The first chamber 5 and the second chamber 6 have through holes 38 and 39, respectively, and the second chamber 5 and the second chamber 6 have a communication chamber 35.
36, and the medicines sealed in the first chamber 5 and the second chamber 6 are mixed in the container part 3.

さらに、連通手段8の別の形態を第8図に示す。Furthermore, another form of the communication means 8 is shown in FIG.

連通手段は、連通体41と破壊部材42と受台44で構
成されている。連通体41は、伸縮可能な蛇腹状の形状
を有している。連通体41は容器部3の一方の外面に液
密に溶着され、連通室45を形成している。
The communication means is composed of a communication body 41, a breaking member 42, and a pedestal 44. The communication body 41 has a bellows-like shape that can be expanded and contracted. The communication body 41 is liquid-tightly welded to one outer surface of the container portion 3 to form a communication chamber 45.

破壊部材42は、連通体41の内部に固定されている。The destruction member 42 is fixed inside the communication body 41.

受台44は、連通体41が溶着されている反対側の容器
部の他方の外面に液密に溶着され、連通室46を形成し
ている。第二室6を構成しているプラスチックシートの
一部に予め連通口49が設けられている。連通口49は
、二枚のプラスチックシートを貫通させたものであって
も良いし、どちらか−枚のプラスチックシートのみ開口
させたものであってもよい。
The pedestal 44 is liquid-tightly welded to the other outer surface of the container portion on the opposite side to which the communication body 41 is welded, and forms a communication chamber 46 . A communication port 49 is provided in advance in a part of the plastic sheet constituting the second chamber 6. The communication port 49 may be formed by penetrating two plastic sheets, or may be formed by opening only one of the plastic sheets.

連通体41を外部から押さえ込み、破壊部材42で第−
室5を形成しているプラスチックシート47を貫通させ
る。そのときの状態を第9図に示す。
The communicating body 41 is pressed down from the outside and the destructive member 42 is used to
The plastic sheet 47 forming the chamber 5 is penetrated. The state at that time is shown in FIG.

次に、連通体41を元に戻す。そのときの状態を第10
図に示す。第−室5には貫通口48ができ、第−室5と
第二室6は連通室45.46で連通され、第−室5と第
二室6に封入されていた薬剤が容器部3の中で混合され
る。
Next, the communicating body 41 is returned to its original position. The state at that time is number 10.
As shown in the figure. A through hole 48 is formed in the first chamber 5, and the first chamber 5 and the second chamber 6 are communicated with each other through a communication chamber 45, 46, and the medicine sealed in the first chamber 5 and the second chamber 6 is transferred to the container part 5. mixed inside.

次に、本発明の容器の製造方法について説明する。容器
部3は、二枚重ねのプラスチックシートで構成されてい
る0口元部2は、射出成形により成形された成形物を用
いて容器部3に溶着している。
Next, a method for manufacturing the container of the present invention will be explained. The container part 3 is made of two stacked plastic sheets, and the mouth part 2 is welded to the container part 3 using a molded product formed by injection molding.

プラスチックシートの材料としては、製法上からくる制
約は殆ど無く、安全性が高く廉価なポリオレフィン系樹
脂はもちろんのこと、変性ポリオレフィン系樹脂、ポリ
エステル系樹脂等容器の目的に適した樹脂を選定するこ
とができる。
As for the material of the plastic sheet, there are almost no restrictions due to manufacturing methods, and it is important to select resins that are suitable for the purpose of the container, such as safe and inexpensive polyolefin resins, modified polyolefin resins, and polyester resins. I can do it.

プラスチックシートは、インフレーション成形、カレン
ダ成形、Tダイ押出成形等により成形される。これらの
成形法により、単層あるいは多層のシートを作製するこ
とができる。
The plastic sheet is formed by inflation molding, calendar molding, T-die extrusion molding, or the like. By these molding methods, single-layer or multi-layer sheets can be produced.

ここでは、カレンダ成形またはTダイ押出成形により作
製されたシートを用いる場合について説明する。まず、
シートを定寸にカットする。次に、熱溶着により、外周
シール11および隔離手段7のシールを行い、容器部3
を形成する。溶着後、懸垂口9および外周シール11の
外側の不用部分を切断し取り除く0次に、連通手段の連
通体21と受台24を容器部3を構成する二枚のプラス
チックシートを挟み込むようにして熱溶着する。このと
き、プラスチックシート同士は溶着されず、連通体21
とプラスチックシートおよび受台24とプラスチックシ
ートが溶着される加熱条件の設定が重要である。
Here, a case will be described in which a sheet produced by calender molding or T-die extrusion molding is used. first,
Cut the sheet to size. Next, the outer seal 11 and the isolation means 7 are sealed by heat welding, and the container part 3 is sealed.
form. After welding, the unnecessary parts on the outside of the suspension opening 9 and the outer peripheral seal 11 are cut and removed.Next, the communicating body 21 and the pedestal 24 of the communicating means are sandwiched between the two plastic sheets constituting the container part 3. Heat weld. At this time, the plastic sheets are not welded together and the communication body 21
It is important to set the heating conditions for welding the plastic sheet and the pedestal 24 to the plastic sheet.

連通体21とプラスチックシートおよび受台24とプラ
スチックシートを溶着させる加熱条件として、加熱温度
、加熱時間、プレスの圧力の設定が基本になるが、加熱
方法の選択により、加熱条件の設定が更に容易になる。
The heating conditions for welding the communication body 21 and the plastic sheet and the pedestal 24 and the plastic sheet are basically the settings of heating temperature, heating time, and press pressure, but the heating conditions can be more easily set by selecting the heating method. become.

すなわち、第11図に示す溶着型51.52で加熱する
場合、片方の溶着型51は加温し他方の溶着型52は加
温せずに、片面ずつ交互に溶着させる方法を採ると、プ
ラスチックシート同士の溶着が起こりにくい。
That is, when heating is performed using the welding molds 51 and 52 shown in FIG. 11, one welding mold 51 is heated and the other welding mold 52 is not heated, and if a method is adopted in which the welding is performed alternately on each side, the plastic Welding between sheets is less likely to occur.

更に、プラスチックシートを二層以上の多層シートを用
いることにより、連通体21とプラスチックシートおよ
び受台24とプラスチックシートを溶着させる加熱条件
の設定を容易にすることができる。容器部3の内面に相
当するシートの最内層を構成する樹脂と容器部3の外面
に相当するシートの最外層を構成する樹脂は、溶着温度
が異なるものを用いることができ、最外層を構成する樹
脂より最内層を構成する樹脂のほうが溶着温度が高いも
のを選定することにより、プラスチックシートの内面同
士は溶着されず、連通体21とプラスチックシートの外
面および受台24とプラスチックシートの外面を溶着さ
せる加熱条件の設定が容易になる6例えば、最内層に高
密度ポリエチレンで最外層に低密度ポリエチレンまたは
直鎖状低密度ポリエチレンの組み合わせや、最内層にポ
リプロピレンで最外層に低密度ポリエチレンまたは直鎖
状低密度ポリエチレンの組み合わせや、最内層にポリプ
ロピレンと直鎖状低密度ポリエチレンの混合樹脂で最外
層に直鎖状低密度ポリエチレンの組み合わせ等が考えら
れる。
Furthermore, by using a multilayer plastic sheet having two or more layers, it is possible to easily set the heating conditions for welding the communicating body 21 and the plastic sheet, and the pedestal 24 and the plastic sheet. The resin constituting the innermost layer of the sheet corresponding to the inner surface of the container part 3 and the resin constituting the outermost layer of the sheet corresponding to the outer surface of the container part 3 may have different welding temperatures, and the resin constituting the outermost layer By selecting a resin that has a higher welding temperature than the resin that makes up the innermost layer, the inner surfaces of the plastic sheets are not welded together, and the connecting body 21 and the outer surface of the plastic sheet, and the pedestal 24 and the outer surface of the plastic sheet are bonded together. It is easier to set the heating conditions for welding6. For example, the innermost layer is high density polyethylene and the outermost layer is low density polyethylene or linear low density polyethylene, or the innermost layer is polypropylene and the outermost layer is low density polyethylene or linear low density polyethylene. Possible combinations include a combination of linear low-density polyethylene, a mixed resin of polypropylene and linear low-density polyethylene for the innermost layer, and linear low-density polyethylene for the outermost layer.

[実施例] 以下、実m例をあげて本発明をより具体的に説明する。[Example] Hereinafter, the present invention will be explained in more detail using actual examples.

実施例1 直鎖状低密度ポリエチレン〈密度0.9228/ctl
i)を用いてインフレーション成形により、折り径25
0mmで肉厚0.25+*mのインフレーションチュー
ブを作製した。このインフレーションチューブを第1図
に示すような外周シールと隔離手段を160℃で5秒間
加熱し熱溶着した。外周シールの外側及び懸垂口の不要
部分を切断除去した。別に、直鎖状低密度ポリエチレン
(密度0.920 g/d’)を用いて射出成形により
第1図に示す口元部の成形物を作製し、外周シールされ
たインフレーションチューブに溶着した。
Example 1 Linear low density polyethylene (density 0.9228/ctl)
i) by inflation molding to create a fold diameter of 25
An inflation tube with a thickness of 0 mm and a wall thickness of 0.25+*m was produced. This inflation tube was heated at 160° C. for 5 seconds to heat weld the outer peripheral seal and isolation means as shown in FIG. 1. The outside of the outer seal and the unnecessary parts of the suspension port were cut and removed. Separately, a molded mouth part shown in FIG. 1 was produced by injection molding using linear low-density polyethylene (density 0.920 g/d'), and welded to an inflation tube whose outer periphery was sealed.

次に、直鎖状低密度ポリエチレン(密度0.935g/
CIA)を用いて、第2図に示す連通体と受台を射出成
形により作製した。また、ガラスフィラー入りポリプロ
ピレンを用いて、第2図に示す破壊部材を射出成形によ
り作製した。連通体と破壊部材を熱溶着により固定した
ものと受台を第11図に示すように溶着型で挟み込む、
下側を室温まで冷却し上側を200℃で5秒間加熱して
、連通体とインフレチューブの片側の面を溶着する。次
に、インフレチューブと連通体を表裏反転させ、同様に
受台とインフレチューブの他方の面を溶着する。
Next, linear low density polyethylene (density 0.935g/
The communicating body and pedestal shown in FIG. 2 were manufactured by injection molding using CIA). Furthermore, a breakable member shown in FIG. 2 was manufactured by injection molding using glass filler-containing polypropylene. The communicating body and the destructive member are fixed by heat welding, and the pedestal is sandwiched between welding molds as shown in Fig. 11.
The lower side is cooled to room temperature and the upper side is heated at 200° C. for 5 seconds to weld the communicating body and one side of the inflation tube. Next, the inflation tube and the communication body are turned over, and the other side of the pedestal and the inflation tube are similarly welded.

このとき、インフレーションチューブ同士は溶着されな
かった。
At this time, the inflation tubes were not welded together.

以上のようにして、輸液用容器を作製した。An infusion container was produced in the manner described above.

この容器の第−室に高カロリー輸液の基本液600mを
、第二室にアミノ酸輸液300−を注入し、開口部を直
鎖状低密度ポリエチレン製フィルムで密封しゴム栓を装
着した。
600 m of the basic high-calorie infusion was injected into the first chamber of this container, and 300 m of the amino acid infusion into the second chamber, and the opening was sealed with a linear low-density polyethylene film and fitted with a rubber stopper.

この輸液容器を115°Cで40分間高圧蒸気滅菌をし
たが、滅菌後著しい変形および第−室と第二室間の連通
は見られなかった。また、加圧してリーク試験をおこな
ったが、各溶着部からは、内容液の漏出はなかった。
This infusion container was autoclaved at 115° C. for 40 minutes, but no significant deformation or communication between the first and second chambers was observed after sterilization. In addition, a leak test was conducted under pressurization, but there was no leakage of the liquid content from each welded portion.

次に、連通手段の連通体を外部から押さえ付は破壊部材
によりインフレチューブを貫通させ、貫通口を通じて第
二室のアミノ酸輸液を第−室に導入し、第一室内でアミ
ノ酸輸液と高カロリー輸液の基本液を混合した。
Next, the communicating body of the communication means is pressed from the outside and the inflation tube is penetrated by a destructive member, and the amino acid infusion in the second chamber is introduced into the second chamber through the through hole, and the amino acid infusion and high-calorie infusion are injected into the first chamber. The base liquid was mixed.

次に、常の輸液手技に従って輸液セットのビン針を開口
部に貫通させ、開口部から輸注用の針までの高さを70
cmとし、クレンメで滴下量が約50m I/分となる
ように調整固定し、排液量と時間との関係を測定したと
ころ、排液量は時間にほぼ比例した。
Next, according to the usual infusion technique, the bottle needle of the infusion set is passed through the opening, and the height from the opening to the infusion needle is 70 mm.
When the relationship between the amount of drained liquid and time was measured, the amount of drained liquid was approximately proportional to time.

実施例2 外層に直鎖状低密度ポリエチレン(密度0.922g1
ont)を内層に直鎖状低密度ポリエチレン(密度0.
90  gr7)とポリプロピレン(密度0.90g/
crA〉の1/1の混合樹脂を用いてインフレーション
成形により、折り径250 +*mで肉厚0,25關の
二層のインフレーションチューブを作製した。
Example 2 Linear low density polyethylene (density 0.922g1
ont) as the inner layer and linear low density polyethylene (density 0.
90 gr7) and polypropylene (density 0.90 g/
A two-layer inflation tube with a fold diameter of 250 + * m and a wall thickness of 0.25 mm was produced by inflation molding using a mixed resin of 1/1 of crA>.

このインフレーションチューブを第1図に示すような外
周シールと隔離手段を230℃で5秒間加熱し熱溶着し
た。外周シールの外側及び懸垂口の不要部分を切断除去
した。別に、直鎖状低密度ポリエチレン(密度0.92
0 g / crl )を用いて射出成形により第1図
に示す口元部の成形物を作製し、外周シールされたイン
フレーションチューブに溶着した。
This inflation tube was heated at 230° C. for 5 seconds to heat weld the outer peripheral seal and isolation means as shown in FIG. 1. The outside of the outer seal and the unnecessary parts of the suspension port were cut and removed. Separately, linear low-density polyethylene (density 0.92
A molded article with a mouth portion shown in FIG. 1 was produced by injection molding using a material (0 g/crl) and welded to an inflation tube whose outer periphery was sealed.

次に、直鎖状低密度ポリエチレン(密度0.935g/
co()を用いて、第2図に示す連通体と受台を射出成
形により作製した。また、ガラスフィラー人りポリプロ
ピレンを用いて、第2図に示す破壊部材を射出成形によ
り作製した。連通体と破壊部材を熱溶着により固定した
ものと受台を第11図に示すように溶着型で挟み込み、
上下から190°Cで4秒間加熱し、連通体とインフレ
ーションチューブ、受台とインフレーションチューブを
熱溶着する。このとき、インフレーションチューブ同士
は溶着されなかった。
Next, linear low density polyethylene (density 0.935g/
A communicating body and a pedestal shown in FIG. 2 were manufactured by injection molding using co(). Further, a breakable member shown in FIG. 2 was produced by injection molding using glass filler polypropylene. The communicating body and the destructible member are fixed by heat welding, and the pedestal is sandwiched between welding molds as shown in Fig. 11.
Heat at 190°C for 4 seconds from the top and bottom to heat weld the communicating body and the inflation tube, and the pedestal and the inflation tube. At this time, the inflation tubes were not welded together.

以上のようにして、輸液用容器を作製した。An infusion container was produced in the manner described above.

この容器の第−室に高カロリー輸液の基本液600−を
、第二室にアミノ酸輸液300−を注入し、開口部を直
鎖状低密度ポリエチレン製フィルムで密封しゴム栓を装
着した。
A basic high-calorie infusion solution 600- was injected into the first chamber of this container, and an amino acid infusion 300- was injected into the second chamber, and the opening was sealed with a linear low-density polyethylene film and a rubber stopper was attached.

この輸液容器を115℃で40分間高圧蒸気滅菌をした
が、滅菌後著しい変形および第−室と第二室間の連通は
見られなかった。また、加圧してリーク試験をおこなっ
たが、各溶着部からは、内容液の漏出はなかった。
This infusion container was autoclaved at 115° C. for 40 minutes, but no significant deformation or communication between the first and second chambers was observed after sterilization. In addition, a leak test was conducted under pressurization, but there was no leakage of the liquid content from each welded part.

次に、連通手段の連通体を外部から押さえ付は破壊部材
によりインフレチューブを貫通させ、貫通口を通じて第
二室のアミノ酸輸液を第−室に導入し、第一室内でアミ
ノ酸輸液と高カロリー輸液の基本液を混合した。
Next, the communicating body of the communication means is pressed from the outside and the inflation tube is penetrated by a destructive member, and the amino acid infusion in the second chamber is introduced into the second chamber through the through hole, and the amino acid infusion and high-calorie infusion are injected into the first chamber. The base liquid was mixed.

次に、常の輸液手技に従って輸液セットのビン針を開口
部に貫通させ、開口部から輸注用の針までの高さを70
cmとし、クレンメで滴下量が約50m I/分となる
ように調整固定し、排液量と時間との関係を測定したと
ころ、排液量は時間にほぼ比例した。
Next, according to the usual infusion technique, the bottle needle of the infusion set is passed through the opening, and the height from the opening to the infusion needle is 70 mm.
When the relationship between the amount of drained liquid and time was measured, the amount of drained liquid was approximately proportional to time.

[発明の効果コ 以上述べたように、本発明の複数の室を有する薬剤入り
容器は以下に示す利点を有する。
[Effects of the Invention] As described above, the drug-containing container having a plurality of chambers of the present invention has the following advantages.

■使用時まで、複数の各室は確実に隔離されており、使
用時には容易にかつ確実に各室を連通させることができ
る。
■The multiple chambers are reliably isolated until use, and each chamber can be easily and reliably communicated with each other during use.

■容器の製造工程が、すべて外部からの加工で済むので
、製造が容易である。
■Manufacturing is easy because the container manufacturing process only requires external processing.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明の複数の室を有する薬剤入り容器の一実
施例を示す正面図、第2図は連通手段の第一実施例を示
す断面図、第3図は同連通手段を用いて貫通口を形成し
ているところを示す断面図、第4図は同連通手段を用い
て貫通口を形成して複数の室が連通しているところを示
す断面図、第5図は連通手段の第二実施例を示す断面図
、第6図は同連通手段を用いて貫通口を形成していると
ころを示す断面図、第7図は同連通手段を用いて貫通口
を形成して複数の室が連通しているところを示す断面図
、第8図は連通手段の第三実施例を示す断面図、第9図
は同連通手段を用いて貫通口を形成しているところを示
す断面図、第10図は同連通手段を用いて貫通口を形成
して複数の室が連通しているところを示す断面図、第1
1図は連通手段を容器部に熱溶着しているところを示す
断面図、第12図は連通手段にストッパーを設置したと
ころを示す断面図である。 1・・・容器、   2・・・口元部、  3・・・容
器部、4・・・懸垂口部、 5・・・第−室   6・
・・第二室、7・・・隔離手段、 8・・・連通手段、
 9・・・懸垂口、10・・・栓、   11・・・外
周シール、21.31.41・・・連通体、 22.23,32.42・・・破壊部材、24.34.
44・・・受台、
FIG. 1 is a front view showing an embodiment of a drug-containing container having a plurality of chambers according to the present invention, FIG. 2 is a cross-sectional view showing a first embodiment of a communication means, and FIG. 4 is a cross-sectional view showing how a through hole is formed using the same communication means and a plurality of chambers communicate with each other. FIG. A cross-sectional view showing the second embodiment, FIG. 6 is a cross-sectional view showing how a through hole is formed using the same communication means, and FIG. 8 is a sectional view showing a third embodiment of the communication means, and FIG. 9 is a sectional view showing a through hole being formed using the same communication means. , FIG. 10 is a cross-sectional view showing a plurality of chambers communicating with each other by forming a through hole using the same communication means.
FIG. 1 is a cross-sectional view showing the communicating means heat-welded to the container part, and FIG. 12 is a cross-sectional view showing the communicating means with a stopper installed. 1... Container, 2... Mouth part, 3... Container part, 4... Hanging mouth part, 5... Third chamber 6.
...Second room, 7.Isolation means, 8.Communication means,
9... Suspension port, 10... Plug, 11... Outer seal, 21.31.41... Communication body, 22.23, 32.42... Destruction member, 24.34.
44... pedestal,

Claims (3)

【特許請求の範囲】[Claims] (1)複数の室とそれぞれの室を連結する連通手段から
なる容器であって、前記連通手段で構成される連通室は
少なくとも一方の室を構成する部材によって遮蔽されて
おり、前記室を構成する部材を破壊することにより前記
連通手段で構成される連通室を介してそれぞれの室に封
入されている薬剤を混合することを特徴とする複数の室
を有する薬剤入り容器。
(1) A container consisting of a plurality of chambers and communication means connecting the respective chambers, wherein the communication chamber constituted by the communication means is shielded by a member constituting at least one of the chambers, and the communication chamber constituted by the communication means is shielded by a member constituting at least one chamber, A drug-containing container having a plurality of chambers, characterized in that the drugs sealed in the respective chambers are mixed through the communication chambers constituted by the communication means by breaking the connecting member.
(2)前記連通手段が前記室を構成する部材を容易に破
壊することができる破壊部材を有することを特徴とする
特許請求の範囲第1項に記載の複数の室を有する薬剤入
り容器。
(2) A drug-containing container having a plurality of chambers as set forth in claim 1, wherein the communication means has a destruction member that can easily destroy the members constituting the chambers.
(3)前記連通手段が連通室を構成する連通体と前記連
通室の内部に存在する破壊部材と前記破壊部材を受ける
受台から構成されていることを特徴とする特許請求の範
囲第1項または第2項に記載の複数の室を有する薬剤入
り容器。
(3) Claim 1, wherein the communication means is comprised of a communication body constituting a communication chamber, a destructible member existing inside the communication chamber, and a pedestal for receiving the destructible member. Or a drug-containing container having a plurality of chambers according to item 2.
JP2033515A 1990-02-14 1990-02-14 Drug-contained receptacle having plural chambers Pending JPH03236847A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2033515A JPH03236847A (en) 1990-02-14 1990-02-14 Drug-contained receptacle having plural chambers
DE69111480T DE69111480T2 (en) 1990-02-14 1991-02-09 Filled and sealed, independent mixing container.
EP19910101846 EP0442406B1 (en) 1990-02-14 1991-02-09 Filled and sealed, self-contained mixing container
US07/654,037 US5114004A (en) 1990-02-14 1991-02-12 Filled and sealed, self-contained mixing container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2033515A JPH03236847A (en) 1990-02-14 1990-02-14 Drug-contained receptacle having plural chambers

Publications (1)

Publication Number Publication Date
JPH03236847A true JPH03236847A (en) 1991-10-22

Family

ID=12388682

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2033515A Pending JPH03236847A (en) 1990-02-14 1990-02-14 Drug-contained receptacle having plural chambers

Country Status (1)

Country Link
JP (1) JPH03236847A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021890A1 (en) * 1992-05-03 1993-11-11 Otsuka Pharmaceutical Factory, Inc. Vessel having a plurality of chambers
US5423421A (en) * 1992-05-03 1995-06-13 Otsuka Pharmaceutical Factory, Inc. Containers having plurality of chambers

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021890A1 (en) * 1992-05-03 1993-11-11 Otsuka Pharmaceutical Factory, Inc. Vessel having a plurality of chambers
AU654442B2 (en) * 1992-05-03 1994-11-03 Otsuka Pharmaceutical Factory, Inc. Vessel having a plurality of chambers
US5423421A (en) * 1992-05-03 1995-06-13 Otsuka Pharmaceutical Factory, Inc. Containers having plurality of chambers

Similar Documents

Publication Publication Date Title
US5114004A (en) Filled and sealed, self-contained mixing container
US8343128B2 (en) Multiple-chamber medical container and bag for enclosing same
JP2675049B2 (en) Container with contents
US7789852B2 (en) Medical liquid container and preparation-containing medical liquid container
TWI226234B (en) Multiple-chamber medical container and method for producing the same
US9902508B2 (en) Delivery device with separate chambers connectable in fluid communication when ready for use, and related method
JPH0626563B2 (en) Medical container and manufacturing method thereof
JP4483037B2 (en) Resin container for enclosing medical liquid and port member
RU2352320C2 (en) Vessel for medical liquids and vessel for medical liquids containing preparation
JP2994417B2 (en) Medicine container
JPH03236847A (en) Drug-contained receptacle having plural chambers
JP4581331B2 (en) Drug-filled multi-chamber bag
JP4822860B2 (en) Medical multi-chamber container
CN104188801B (en) Powder-liquid double-chamber infusion bag and preparing method thereof
JP4239198B2 (en) Small volume mixed injection container and multi-bag using the same
JP2562864Y2 (en) Mixing container with contents
JP2004313487A (en) Medical purpose double chamber vessel and its production method
JP3932427B2 (en) Manufacturing method of medical multi-chamber container
JP2882839B2 (en) Container with contents for mixing
JPH11313871A (en) Infusion vessel
JPH1071185A (en) Vessel for medical treatment